The January 20, 2012 article by Tarhini et al, entitled, “Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma” (J Clin Oncol 30:322-328, 2012), contained an error.
The following was inadvertently omitted and should have been acknowledged in the sidebar of the article:
“The project described was supported by Award Number P50CA121973 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. ”
The authors apologize for the omission.